These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25991028)
1. Evidence informed decision making: the use of "colloquial evidence" at nice. Sharma T; Choudhury M; Kaur B; Naidoo B; Garner S; Littlejohns P; Staniszewska S Int J Technol Assess Health Care; 2015 Jan; 31(3):138-46. PubMed ID: 25991028 [TBL] [Abstract][Full Text] [Related]
2. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Andronis L; Barton P; Bryan S Health Technol Assess; 2009 Jun; 13(29):iii, ix-xi, 1-61. PubMed ID: 19500484 [TBL] [Abstract][Full Text] [Related]
4. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis. Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841 [TBL] [Abstract][Full Text] [Related]
5. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation. Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643 [TBL] [Abstract][Full Text] [Related]
6. Evidence-informed evidence-making. Chalkidou K; Walley T; Culyer A; Littlejohns P; Hoy A J Health Serv Res Policy; 2008 Jul; 13(3):167-73. PubMed ID: 18573766 [TBL] [Abstract][Full Text] [Related]
7. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
8. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
9. Decision making by NICE: examining the influences of evidence, process and context. Cerri KH; Knapp M; Fernández JL Health Econ Policy Law; 2014 Apr; 9(2):119-41. PubMed ID: 23688554 [TBL] [Abstract][Full Text] [Related]
10. A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? Cowles E; Marsden G; Cole A; Devlin N Appl Health Econ Health Policy; 2017 Aug; 15(4):469-477. PubMed ID: 28130691 [TBL] [Abstract][Full Text] [Related]
11. Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation. Peel A; Jenks M; Choudhury M; Lovett R; Rejon-Parrilla JC; Sims A; Craig J Appl Health Econ Health Policy; 2018 Dec; 16(6):819-836. PubMed ID: 30073485 [TBL] [Abstract][Full Text] [Related]
12. Implications of the appraisal function of the National Institute for Clinical Excellence (NICE). Buxton M Value Health; 2001; 4(3):212-6. PubMed ID: 11705183 [TBL] [Abstract][Full Text] [Related]
13. DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK. de Folter J; Trusheim M; Jonsson P; Garner S Int J Technol Assess Health Care; 2018 Jan; 34(2):163-171. PubMed ID: 29633673 [TBL] [Abstract][Full Text] [Related]
14. THE GHOST IN THE MACHINE? THE VALUE OF EXPERT ADVICE IN THE PRODUCTION OF EVIDENCE-BASED GUIDANCE: A MIXED METHODS STUDY OF THE NICE INTERVENTIONAL PROCEDURES PROGRAMME. Oyebode O; Patrick H; Walker A; Campbell B; Powell J Int J Technol Assess Health Care; 2016 Jan; 32(1-2):61-8. PubMed ID: 27001247 [TBL] [Abstract][Full Text] [Related]
15. Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives? Hashem F; Calnan MW; Brown PR Health Expect; 2018 Feb; 21(1):128-137. PubMed ID: 28686809 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical Excellence. Chalkidou K Issue Brief (Commonw Fund); 2009 Jul; 59():1-12. PubMed ID: 19639713 [TBL] [Abstract][Full Text] [Related]
17. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence. Littlejohns P; Barnett D; Longson C; Lancet Oncol; 2003 Apr; 4(4):242-50. PubMed ID: 12681268 [TBL] [Abstract][Full Text] [Related]
18. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062 [TBL] [Abstract][Full Text] [Related]
19. Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care. Chalkidou K; Lord J; Obeidat NA; Alabbadi IA; Stanley AG; Bader R; Momani A; O'Mahony RM; Qatami L; Cutler D Int J Technol Assess Health Care; 2011 Apr; 27(2):151-8. PubMed ID: 21473813 [TBL] [Abstract][Full Text] [Related]
20. "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making. Dakin HA; Devlin NJ; Odeyemi IA Health Policy; 2006 Aug; 77(3):352-67. PubMed ID: 16213624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]